These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 16483032)

  • 41. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of the routine hepatitis B immunization programme in Palestine, 1996.
    Kuhail S; el-Khodary R; Ahmed F
    East Mediterr Health J; 2000; 6(5-6):864-9. PubMed ID: 12197342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B vaccination in persons with isolated hepatitis B core antibodies.
    Liesnard CA
    Clin Infect Dis; 1999 Apr; 28(4):932-3. PubMed ID: 10825079
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.
    Roberts LK; Barr LJ; Fuller DH; McMahon CW; Leese PT; Jones S
    Vaccine; 2005 Sep; 23(40):4867-78. PubMed ID: 15985318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B and the need for a booster dose.
    Leuridan E; Van Damme P
    Clin Infect Dis; 2011 Jul; 53(1):68-75. PubMed ID: 21653306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pre-S/S CHO-derived hepatitis B virus vaccine protects woodchucks from WHV productive infection.
    Argentini C; Giuseppetti R; D'Ugo E; La Sorsa V; Tritarelli E; Orobello S; Canitano A; Glück R; Rapicetta M
    Vaccine; 2005 May; 23(28):3649-56. PubMed ID: 15882525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India.
    Potsangbam G; Yadav A; Chandel N; Rathi M; Sharma A; Kohli HS; Gupta KL; Minz M; Sakhuja V; Jha V
    Nephrology (Carlton); 2011 May; 16(4):383-8. PubMed ID: 21114569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Active preventive vaccination against hepatitis B].
    Jilg W
    Internist (Berl); 1985 Oct; 26(10):633-9. PubMed ID: 2934346
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antibodies against hepatitis B after vaccination in health workers].
    Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
    Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hepatitis B immunization for newborn infants of hepatitis B surface antigen-positive mothers].
    Cowan SA; Qureshi KM
    Ugeskr Laeger; 2007 Oct; 169(41):3471-4. PubMed ID: 17967274
    [No Abstract]   [Full Text] [Related]  

  • 53. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 54. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y; Liu SL; Zhai XJ; Zhu FC; Pan H; Yu JX; Chen YZ; Xie YR; Zhang XY; Zhang HM; Li LJ; Wang H; Ruan B
    J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation.
    Berner J; Kadian M; Post J; Miller C; Schwartz M; Conn M; Borcich A
    Transplant Proc; 1993 Apr; 25(2):1751-2. PubMed ID: 8470152
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B boosters.
    Ide CW
    Occup Med (Lond); 2008 May; 58(3):222-3. PubMed ID: 18441364
    [No Abstract]   [Full Text] [Related]  

  • 57. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
    Marinho RT; Ramalho F; Velosa J
    Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
    [No Abstract]   [Full Text] [Related]  

  • 58. A randomized, multicenter, open-label clinical trial to assess the anamnestic immune response 4 to 8 years after a primary hepatitis B vaccination series.
    Diez-Domingo J; Flores SA; Martin JC; Klopfer SO; Schödel FP; Bhuyan PK
    Pediatr Infect Dis J; 2010 Oct; 29(10):972-4. PubMed ID: 20724955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What you need to know: interpreting hepatitis B viral markers.
    Tan CK
    Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current status of the problem of viral hepatitis B prophylaxis].
    Golosova TV; Vlasikhina EM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.